/
Biological products, (no diagnostic substances) company · L3 · FY ends Dec · Revenue $1M · -575.29% margin · -$6M FCF
The business is unprofitable at the operating level (-575.29% margin). The thesis depends entirely on whether and when it reaches sustainable profitability.
Revenue up 99.2% YoY with margins expanding 737.5pp.
Negative free cash flow of -$6M. The business is consuming cash, not generating it.
Profitability & Returns
Revenue (TTM)
$1M
▲ +99.2% YoY
Net Income (TTM)
-$8M
▼ -273.2% YoY
Op. Margin
-575.29%
▲ +737.5pp YoY
ROIC
-54.49%
▲ +107.5pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
-$6M
▲ +4.6% YoY
Op. Cash Flow (TTM)
-$6M
▲ +4.8% YoY
Net Debt
$300K
Cash & Equiv.
$2M
Continue Research